AMANDA RASCON: Open Payments
NPI 1063157253 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 12 payments from 4 companies in 2025. Trend: 2023 $910 · 2024 $348 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $148 |
| ABBVIE INC. | 7 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $117 |
| Dexcom, Inc. | 1 | $28 |
Products named: PROCLAIM, QULIPTA, CAPLYTA, Dexcom G6 Transmitter, OCTRODE, UBRELVY.
Industry payments across AZ — which companies pay providers there.
